Adult female in good health
Conditions
Interventions
None listed
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1)Subjects who can visit to a designated clinic on scheduled inspection date. (2) Subjects who understand the explanation about this study given beforehand and submit written informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: (1) Subjects who are under continuous treatment of medical supplies. (2) Females who are pregnant (including the possibility of pregnancy) or are lactating. (3) Subjects who donated 200 mL of blood and/or blood components within four weeks prior to the current study. (4) Females whose blood was collected more than 400 mL within the last 16-weeks. (5) Females whose blood was collected more than 800 mL within the last 12-months when the amount of blood sampling in the current study is added. (6) Subjects who are participating in other clinical studies for drug medicine or food, or who finished clinical study within 4-weeks. (7)Subjects who are heavy drinkers of alcohol and/or are excessive smokers (smoking 21 and more per day). (8) Subjects who have an excessive irregular meal cycle, a work shift or a work on midnight shift. (9)Subject who are true to one of the below. a) Subject who are suffering from heart, liver or kidney disease, including the case of complications of other disease. b) Subjects who are suffering from diabetes. (10) Subjects who have long trip planning during test period. (11) Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microflora, by 16S metagenome analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Metabolite in intestine, by metabolome analysis. | — |
Countries
Japan
Contacts
Public ContactSuguru Fujiwara
CPCC Company Limited Clinical Research Planning Department
Outcome results
None listed